Mechanisms of Skin Repair by Topical Estrogen
NCT00113100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152
Last updated 2015-05-21
Summary
The purpose of this study is to investigate the way by which estrogen improves the appearance of sun damaged human skin. Accumulating evidence suggests that estrogen, taken by post menopausal women, may cause skin to look younger as a consequence of reduced wrinkles. Collagen is the most abundant protein in human skin and gives skin its strength and shape. Recent data indicate that short-term topical estrogen (17-beta estradiol) treatment increases collagen production in sun damaged skin. This study will compare the molecular and microscopic effects from topical 17-beta estradiol (E2) when applied to the skin for a short-term duration. It is anticipated that the new knowledge from this study will enable development of new ways to improve the function of aged skin.
Conditions
- Skin Wrinkling
Interventions
- DRUG
-
Topical 17-beta estradiol in ethanol/propylene glycol (ETOH/PG)
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John J Voorhees, MD · University of Michigan
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-08-31
- Primary Completion
- 2007-06-30
- Completion
- 2007-06-30
Countries
- United States
Study Locations
More Related Trials
-
Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
NCT01553773 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Estradiol on Endothelial Function in Peri-Menopausal Women
NCT04255160 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
NCT00391417 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial
NCT07260825 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
NCT02449902 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)
NCT01015677 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
NCT01486979 ·Status: COMPLETED ·Phase: PHASE1
-
Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
NCT05586711 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
NCT02224313 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
NCT01816139 ·Status: COMPLETED ·Phase: PHASE3
-
Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women
NCT06808347 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System
NCT00650442 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
NCT00816556 ·Status: TERMINATED ·Phase: PHASE3
-
The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse
NCT00803335 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes
NCT00206622 ·Status: COMPLETED ·Phase: PHASE4
-
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
NCT01070979 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch
NCT00185237 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.
NCT03556800 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
NCT04232813 ·Status: COMPLETED ·Phase: PHASE3
-
Alzheimer's Disease: Therapeutic Potential of Estrogen
NCT00066157 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension
NCT01293747 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Of Spil's Estradiol Vaginal Tablet
NCT01753102 ·Status: TERMINATED ·Phase: PHASE3
-
Transgender Estradiol
NCT04036500 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
NCT00002976 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
NCT01845649 ·Status: COMPLETED ·Phase: PHASE3